Literature DB >> 18094407

The roles of therapy-induced autophagy and necrosis in cancer treatment.

Ravi K Amaravadi1, Craig B Thompson.   

Abstract

Metabolic and therapeutic stresses activate several signal transduction pathways that regulate cell death and cell survival in cancer cells. Although decades of research unraveled the pathways that regulate apoptosis and allowed the development of novel diagnostic and therapeutic modalities in cancer treatment, only recently has the regulation and significance of tumor cell autophagy and necrosis become the focus of investigations. Necrosis is an irreversible inflammatory form of cell death. In contrast, autophagy is a reversible process that can contribute both to tumor cell death and survival. This review describes recent advances in understanding the regulation of autophagy and necrosis and their implications for cancer therapy. Currently available methods to measure autophagy and necrosis are highlighted. The effect of tumor cell autophagy and necrosis on host immunity is explored. Finally, therapeutic approaches that target autophagy and necrosis in cancer are described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094407     DOI: 10.1158/1078-0432.CCR-07-1595

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  182 in total

Review 1.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

Review 2.  Epigenetic therapy of lymphoma using histone deacetylase inhibitors.

Authors:  Maribel Cotto; Fernando Cabanillas; Maribel Tirado; María V García; Eileen Pacheco
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

3.  Non-apoptotic routes to defeat cancer.

Authors:  Jennifer L Guerriero; Dara Ditsworth; Wei-Xing Zong
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

4.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

Review 5.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

6.  Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77.

Authors:  Yuhao Luo; Mridul Roy; Xiaojuan Xiao; Shuming Sun; Long Liang; Huiyong Chen; Yin Fu; Yang Sun; Min Zhu; Mao Ye; Jing Liu
Journal:  Tumour Biol       Date:  2014-12-07

7.  Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma.

Authors:  Xiang-Yuan Wu; Jie Chen; Qing-Hua Cao; Min Dong; Qu Lin; Xin-Juan Fan; Qing Xia; Zhan-Hong Chen; Quentin Liu; Xiang-Bo Wan
Journal:  Tumour Biol       Date:  2012-12-07

8.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.

Authors:  Randie H Kim; Jodi M Coates; Tawnya L Bowles; Gregory P McNerney; Julie Sutcliffe; Jae U Jung; Regina Gandour-Edwards; Frank Y S Chuang; Richard J Bold; Hsing-Jien Kung
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.

Authors:  Tawnya L Bowles; Randie Kim; Joseph Galante; Colin M Parsons; Subbulakshmi Virudachalam; Hsing-Jien Kung; Richard J Bold
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

10.  5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor.

Authors:  Nagarekha Pasupuleti; Leonardo Leon; Kermit L Carraway; Fredric Gorin
Journal:  J Pharmacol Exp Ther       Date:  2012-12-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.